<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fisher ML</submitter><funding>NCI NIH HHS</funding><funding>Cancer Center Support</funding><funding>NIH</funding><funding>NIH HHS</funding><pagination>6246-6258</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8692924</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>81(24)</volume><pubmed_abstract>Bromodomain containing protein 4 (BRD4) plays a critical role in controlling the expression of genes involved in development and cancer. Inactivation of BRD4 inhibits cancer growth, making it a promising anticancer drug target. The cancer stem cell (CSC) population is a key driver of recurrence and metastasis in patients with cancer. Here we show that cancer stem-like cells can be enriched from squamous cell carcinomas (SCC), and that these cells display an aggressive phenotype with enhanced stem cell marker expression, migration, invasion, and tumor growth. BRD4 is highly elevated in this aggressive subpopulation of cells, and its function is critical for these CSC-like properties. Moreover, BRD4 regulates ΔNp63α, a key transcription factor that is essential for epithelial stem cell funct</pubmed_abstract><journal>Cancer research</journal><pubmed_title>BRD4 Regulates Transcription Factor ΔNp63α to Drive a Cancer Stem Cell Phenotype in Squamous Cell Carcinomas.</pubmed_title><pmcid>PMC8692924</pmcid><funding_grant_id>CA247400</funding_grant_id><funding_grant_id>CA225134</funding_grant_id><funding_grant_id>P30 CA045508</funding_grant_id><funding_grant_id>5P30CA045508</funding_grant_id><funding_grant_id>F31 CA247400</funding_grant_id><funding_grant_id>R21 OD018332</funding_grant_id><funding_grant_id>R01CA190997</funding_grant_id><funding_grant_id>R01 CA190997</funding_grant_id><funding_grant_id>R21OD018332</funding_grant_id><funding_grant_id>F32 CA225134</funding_grant_id><pubmed_authors>Balinth S</pubmed_authors><pubmed_authors>Fisher ML</pubmed_authors><pubmed_authors>Mills AA</pubmed_authors><pubmed_authors>Goldberg GL</pubmed_authors><pubmed_authors>Hwangbo Y</pubmed_authors><pubmed_authors>Wu C</pubmed_authors><pubmed_authors>Wilkinson JE</pubmed_authors><pubmed_authors>Ballon C</pubmed_authors></additional><is_claimable>false</is_claimable><name>BRD4 Regulates Transcription Factor ΔNp63α to Drive a Cancer Stem Cell Phenotype in Squamous Cell Carcinomas.</name><description>Bromodomain containing protein 4 (BRD4) plays a critical role in controlling the expression of genes involved in development and cancer. Inactivation of BRD4 inhibits cancer growth, making it a promising anticancer drug target. The cancer stem cell (CSC) population is a key driver of recurrence and metastasis in patients with cancer. Here we show that cancer stem-like cells can be enriched from squamous cell carcinomas (SCC), and that these cells display an aggressive phenotype with enhanced stem cell marker expression, migration, invasion, and tumor growth. BRD4 is highly elevated in this aggressive subpopulation of cells, and its function is critical for these CSC-like properties. Moreover, BRD4 regulates ΔNp63α, a key transcription factor that is essential for epithelial stem cell funct</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-05-18T12:08:31.994Z</modification><creation>2025-04-06T09:02:35.68Z</creation></dates><accession>S-EPMC8692924</accession><cross_references><pubmed>34697072</pubmed><doi>10.1158/0008-5472.can-21-0707</doi><doi>10.1158/0008-5472.CAN-21-0707</doi></cross_references></HashMap>